HomeCompareMACQF vs PFE

MACQF vs PFE: Dividend Comparison 2026

MACQF yields 4132.23% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MACQF wins by $9820624821693.25M in total portfolio value
10 years
MACQF
MACQF
● Live price
4132.23%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9820624821693.30M
Annual income
$9,374,357,923,595,800,000.00
Full MACQF calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — MACQF vs PFE

📍 MACQF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMACQFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MACQF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MACQF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MACQF
Annual income on $10K today (after 15% tax)
$351,239.67/yr
After 10yr DRIP, annual income (after tax)
$7,968,204,235,056,430,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, MACQF beats the other by $7,968,204,235,056,407,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MACQF + PFE for your $10,000?

MACQF: 50%PFE: 50%
100% PFE50/50100% MACQF
Portfolio after 10yr
$4910312410846.67M
Annual income
$4,687,178,961,797,914,000.00/yr
Blended yield
95.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

MACQF
No analyst data
Altman Z
-4.6
Piotroski
1/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MACQF buys
0
PFE buys
0
No recent congressional trades found for MACQF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMACQFPFE
Forward yield4132.23%6.20%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$9820624821693.30M$51.1K
Annual income after 10y$9,374,357,923,595,800,000.00$27,210.54
Total dividends collected$9790222638646.02M$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MACQF vs PFE ($10,000, DRIP)

YearMACQF PortfolioMACQF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$423,923$413,223.14$9,161$701.38+$414.8KMACQF
2$16,825,079$16,371,481.44$8,610$859.79+$16.82MMACQF
3$625,262,165$607,259,329.87$8,366$1,081.25+$625.25MMACQF
4$21,759,946,941$21,090,916,424.66$8,483$1,405.66+$21759.94MMACQF
5$709,256,669,489$685,973,526,262.01$9,084$1,907.24+$709256.66MMACQF
6$21,655,194,018,668$20,896,289,382,315.30$10,418$2,732.78+$21655194.01MMACQF
7$619,442,550,970,941$596,271,493,370,966.20$13,007$4,193.56+$619442550.96MMACQF
8$16,603,203,890,261,478$15,940,400,360,722,570.00$18,010$7,005.87+$16603203890.24MMACQF
9$417,071,867,380,837,600$399,306,439,218,257,900.00$28,216$12,979.89+$417071867380.81MMACQF
10$9,820,624,821,693,297,000$9,374,357,923,595,800,000.00$51,081$27,210.54+$9820624821693.25MMACQF

MACQF vs PFE: Complete Analysis 2026

MACQFStock

THEMAC Resources Group Limited engages in acquiring, exploring, and developing natural resource properties in the United States. It explores for copper, gold, silver, and molybdenum deposits. The company's principal property is the Copper Flat project, which consists of 28 patented and 202 unpatented lode mining claims, 4 patented and 41 unpatented placer mining claims, 9 unpatented mill sites, and 16 fee land parcels in contiguous and non-contiguous land parcels and claim blocks located in the Hillsboro mining district of Sierra County, New Mexico. THEMAC Resources Group was incorporated in 1997 and is based in Vancouver, Canada.

Full MACQF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this MACQF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MACQF vs SCHDMACQF vs JEPIMACQF vs OMACQF vs KOMACQF vs MAINMACQF vs JNJMACQF vs MRKMACQF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.